NBC News (11/13, Sullivan) reports “Ozempic [semaglutide] and Wegovy [semaglutide] may help people cut back on drinking, new research” suggests. In a study of about “228,000 people in Sweden who had alcohol use disorder, researchers found that people who were taking a GLP-1 drug like semaglutide were less likely to be hospitalized for alcohol-related issues.” The findings were published in JAMA Psychiatry.
Related Links:
— “Ozempic and Wegovy may help curb alcohol addiction, study suggests,” Kaitlin Sullivan, NBC News, November 13, 2024